Skip to main content
Top

Annals of Hematology

Issue Special Issue 1/2005

Content (11 Articles)

Original Article

Decitabine: a historical review of the development of an epigenetic drug

Dick de Vos, Wendy van Overveld

Original Article

Clinical experience with decitabine in North American patients with myelodysplastic syndrome

Karen W. L. Yee, Elias Jabbour, Hagop M. Kantarjian, Francis J. Giles

Original Article

Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabine

J. A. Pitako, P. S. Haas, J. Van den Bosch, H. Müller-Berndorff, A. Kündgen, U. Germing, P. W. Wijermans, M. Lübbert

Original Article

In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies

Björn Hackanson, Christian Robbel, Pierre Wijermans, Michael Lübbert

Original Article

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

Oliver Galm, Stefan Wilop, Christian Lüders, Edgar Jost, Gerald Gehbauer, James G. Herman, Rainhardt Osieka

Original Article

Decitabine activates specific caspases downstream of p73 in myeloid leukemia

Ingo Tamm, Mandy Wagner, Karin Schmelz

Original Article

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

Andrea Kuendgen, Sabine Knipp, Frank Fox, Corinna Strupp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Norbert Gattermann

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.